Frequent coauthors
- FUKUDA Seiichi 16
- IZUMISAWA Yasuhiro 16
- KOBAYASHI Hideshi 16
- KATO Masanobu 16
- KOMATSU Toshihiko 16
- NAKAGANE Tsutomu 16
- ONO Hajime 16
- OGOSE Naohito 16
- TAKAHASHI Masayuki 16
- TSUCHIDA Yoshio 16
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…
An s-triazine derivative represented by general formula (I), or a pharmaceutically acceptable acid addition salt thereof, and a remedy for estrogen-dependent diseases containing the derivative as the active ingredient, wherein: (1) R1 and R…